Top Medicaid official says Republicans’ proposed reforms are ‘just plain bad policy’

Business of Health Care Reporter

Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes what we all pay for care. He is also the author of the Health Care Inc. newsletter.

ICER Draft Report Critiques Lykos’ MDMA Therapy for Insufficient Evidence

The TDR Three Takeaways for Lykos: ICER’s draft report on Lykos’ MDMA-assisted psychotherapy labels clinical evidence as ‘insufficient’ for PTSD treatment. Concerns over trial design

April 1, 2024

TG licenses Precision’s cell therapy; Innovent’s PhIII weight loss win; Atea’s positive hep C data

Plus news about Elicio Therapeutics, Boehringer Ingelheim, Chiesi, Oak Hill Bio and Zealand Pharma: TG Therapeutics licensed Precision BioSciences’ cell therapy for autoimmune diseases: TG will

January 10, 2024

Government seeks views on proposed changes to the Health Protection Notification Regulations 2010

The Health Protection Notification Regulations 2010 (HPNR) help us respond promptly to suspected cases of infectious disease that could have an impact on public health.

July 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.